Device Trial Radar · NCT06578650
A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms
Last checked: Nov 19, 2026Latest source record: Jun 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
34
Planned (sponsor's estimate)
Start
Oct 31, 2024
Primary completion
Aug 2027
Study completion Oct 2027
Sponsor
- Lead sponsor
- Acera Surgical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 29, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this observational prospective study is to evaluate wound healing outcomes in resection wounds resulting from surgical removal of cutaneous malignancies treated with a synthetic electrospun fiber matrix. This study intends to quantify the time from initial resection and product application to time of complete granulation of the wound bed in weeks.
Conditions
- Surgical Wound
Interventions
Synthetic Electrospun Fiber MatrixDevice
Patients who are eligible for enrollment will be treated with Synthetic Electrospun Fiber Matrix immediately after surgical resection to the resulting wound
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to wound bed granulationTime frame: Weekly assessments until granulation achieved or up to 6 weeks following resection surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Nevada - Las Vegas
Las Vegas, Nevada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.